Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    June 2017
  1. LESTER-COLL NH, Johnson S, Magnuson WJ, Goldhaber SZ, et al
    Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    March 2017
  2. KELLY SP, Graubard BI, Andreotti G, Younes N, et al
    Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    January 2017

  3. Stat Bite Prostate Cancer Incidence and Death Rates.
    J Natl Cancer Inst. 2017;109:6.
    PubMed     Text format    


  4. SCHMIDT C
    Reconsidering Prostate Cancer Screening.
    J Natl Cancer Inst. 2017;109:1-2.
    PubMed     Text format    


    December 2016
  5. UNGER JM, Till C, Thompson IM Jr, Tangen CM, et al
    Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    November 2016
  6. YANG M, Sesso HD, Colditz GA, Ma J, et al
    Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  7. ALLEN NE, Travis RC, Appleby PN, Albanes D, et al
    Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    October 2016
  8. BRATT O, Drevin L, Akre O, Garmo H, et al
    Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    September 2016
  9. SIDDIQUI MM, George AK, Rubin R, Rais-Bahrami S, et al
    Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    July 2016
  10. HAN Y, Rand KA, Hazelett DJ, Ingles SA, et al
    Prostate Cancer Susceptibility in Men of African Ancestry at 8q24.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  11. SHIOTA M, Fujimoto N, Imada K, Yokomizo A, et al
    Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    May 2016
  12. ASIM M, Massie CE, Orafidiya F, Pertega-Gomes N, et al
    Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  13. ABOU DS, Ulmert D, Doucet M, Hobbs RF, et al
    Whole-Body and Microenvironmental Localization of Radium-223 in Naive and Mouse Models of Prostate Cancer Metastasis.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  14. ZHENG Z, Yabroff KR, Guy GP Jr, Han X, et al
    Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  15. DELUDE C
    Prostate Cancer: A New Twist on Active Surveillance.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    April 2016

  16. Stat Bite Percentage of New Cases by Age Group For Prostate Cancer (2008-2012).
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  17. SCHMIDT C
    Active Surveillance Gets Personal.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    March 2016
  18. KENFIELD SA, Batista JL, Jahn JL, Downer MK, et al
    Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    February 2016
  19. AHEARN TU, Pettersson A, Ebot EM, Gerke T, et al
    A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  20. MEEKS HD, Song H, Michailidou K, Bolla MK, et al
    BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  21. KIM JJ, Tosteson AN, Zauber AG, Sprague BL, et al
    Cancer Models and Real-world Data: Better Together.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  22. TENG CJ, Hu YW, Chen SC, Yeh CM, et al
    Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    January 2016
  23. ALFANO CM, Bluethmann SM, Tesauro G, Perna F, et al
    NCI Funding Trends and Priorities in Physical Activity and Energy Balance Research Among Cancer Survivors.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    December 2015
  24. SWEENEY C, Nakabayashi M, Regan M, Xie W, et al
    The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).
    J Natl Cancer Inst. 2015;107:djv261.
    PubMed     Text format     Abstract available


    November 2015
  25. HUNG RJ, Ulrich CM, Goode EL, Brhane Y, et al
    Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  26. BARTH SD, Schulze JJ, Kuhn T, Raschke E, et al
    Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    October 2015
  27. HOSKIN P, Sundar S, Reczko K, Forsyth S, et al
    A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    September 2015
  28. BRIGANTI A, Gandaglia G, Fossati N, Moschini M, et al
    RE: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  29. SCHMIDT C
    Focal Therapy Gains Ground in Low-Risk Prostate Cancer.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  30. LIN CC, Gray PJ, Jemal A, Efstathiou JA, et al
    Response.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  31. AZVOLINSKY A
    Androgen Deprivation Therapy-Linked Cardiovascular Disease Risk: Still Unresolved.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


    July 2015
  32. LIN CC, Gray PJ, Jemal A, Efstathiou JA, et al
    Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  33. BRYANT RJ, Sjoberg DD, Vickers AJ, Robinson MC, et al
    Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    June 2015
  34. HEIJNSDIJK EA, de Koning HJ
    Response.
    J Natl Cancer Inst. 2015;107:djv111.
    PubMed     Text format    


  35. TRINH QD, Nguyen PL, Leow JJ, Dalela D, et al
    Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment.
    J Natl Cancer Inst. 2015;107:djv054.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: